Cellebrite DI Ltd. (NASDAQ:CLBT) Receives Consensus Rating of "Buy" from Analysts
Shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Get Rating) have been assigned a consensus rating of “Buy” from the eight brokerages that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 month price […]